ABIVAX Société Anonyme (LON:0RA9)

Ligand Pharmaceuticals Revenue

ABIVAX Société Anonyme had revenue of 4.01M EUR in the half year ending December 31, 2024, with 78.20% growth. This brings the company's revenue in the last twelve months to 10.59M, up 128.98% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.

• Revenue (ttm): 10.59M EUR
• Revenue Growth: +128.98%
• P/S Ratio: 454.98
• Revenue / Employee: 153.45K EUR
• Employees: 69
• Market Cap: 4.03B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.79M	6.22M	135.94%
Dec 31, 2023	4.57M	69.00K	1.53%
Dec 31, 2022	4.51M	302.00K	7.19%
Dec 31, 2021	4.20M	4.19M	29,921.43%
Dec 31, 2020	14.00K	21.00K	-300.00%